Bausch+Lomb Results Presentation Deck
LUMIFY®: Strong Established Brand with Expansion Opportunities
+21% reported revenue growth in FY22 vs. FY21
+$125M brand4 expanding through geographies
and line extensions
0%
BAUSCH + LOMB
20%
5%
Lumify® Canada Launch Mirroring Success of U.S. Launch
(Lumify Dollar Share Evolution in Redness Reliever Category Since Launch)³
7%
#1 Physician-recommended product in the
Redness Reliever category¹
-50% market share in Redness Reliever Category²
16%
1. IQVIA ProVoice Survey Data Ending Q3 2022.
2. IRI Panel Omnichannel. Dollar share.
13 Week Periods
-50%
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
3. B+L Consumer Data Science USA IRI, CAN Nielsen.
4. Based on trailing twelve-month revenue.
U.S.
Canada
Expansion Opportunities for Future
Growth in the Lumify® Franchise
BAUSCH COMB
LUMIFY
*Lishers
Serta
200
EINE
LUMIFY
SAUBER LOG
LUMIFY
Global expansion with 6 countries,
including U.S. and Canada
Recently acquired rights for 18
additional countries
Lumify® Eye Illuminations -
Expected Launch 1Q23
Specialty eye care line scientifically
developed for the sensitive eye area
to help enhance eyes' natural beauty
Lumify® Preservative Free
(Single Dose)
Submission expected 2Q23
Combination product with ketotifen
for allergy symptom control
Submission expected in 1024
19View entire presentation